Contemporary management of lymph node metastases from an unknown primary to the neck: II. A review of therapeutic options

Head and Neck

Volumn 35, Issue 2, 2013, Pages 286-293

  Strojan, Primož ^a   Ferlito, Alfio ^b   Langendijk, Johannes A ^c   Corry, June ^d   Woolgar, Julia A ^e   Rinaldo, Alessandra ^b   Silver, Carl E ^f   Paleri, Vinidh ^g   Fagan, Johannes J ^h   Pellitteri, Phillip K ⁱ   Haigentz Jr , Missak ^f   Suárez, Carlos ^j,k   Robbins, K Thomas ^l   Rodrigo, Juan P ^j,k   Olsen, Kerry D ^m   Hinni, Michael L ⁿ   Werner, Jochen A ^o   Mondin, Vanni ^b   Kowalski, Luiz P ^p   Devaney, Kenneth O ^q   De Bree, Remco ^r   Takes, Robert P ^s   Wolf, Gregory T ^t   Shaha, Ashok R ^u   Genden, Eric M ^v   Barnes, Leon ^w   more..

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b UNIVERSITY OF UDINE   (Italy)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

^e UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^g NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^h UNIVERSITY OF CAPE TOWN   (South Africa)

ⁱ GEISINGER MEDICAL CENTER   (United States)

^j HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^k DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^l SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m MAYO CLINIC   (United States)

ⁿ MAYO CLINIC   (United States)

^o PHILIPPS UNIVERSITY MARBURG   (Germany)

^p A C CAMARGO CANCER CENTER   (Brazil)

^q Allegiance Health ^*  (United States)

^r VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^s RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^t UNIVERSITY OF MICHIGAN   (United States)

^u MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^v MOUNT SINAI MEDICAL CENTER   (United States)

^w UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

more..

Author keywords

(chemo)radiotherapy; cervical lymph node metastases; neck dissection; squamous cell carcinoma; unknown primary tumor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER OF UNKNOWN PRIMARY SITE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CERVICAL LYMPH NODE; CHEMORADIOTHERAPY; CLINICAL RESEARCH; CONSERVATIVE TREATMENT; EARLY CANCER; EMISSION TOMOGRAPHY; FINE NEEDLE ASPIRATION BIOPSY; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTOLOGY; HUMAN; IMAGE GUIDED BIOPSY; IMMUNOHISTOCHEMISTRY; INDUCTION CHEMOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; LYMPH NODE METASTASIS; MULTIMODALITY CANCER THERAPY; NECK CANCER; NECK DISSECTION; OVERALL SURVIVAL; POSITRON; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PRIMARY TUMOR; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION FIELD; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SECOND CANCER; SYSTEMIC THERAPY; TREATMENT RESPONSE; WART VIRUS;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASMS, UNKNOWN PRIMARY; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84872781831     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21899     Document Type: Review

References (53)

1. Issing WJ, Taleban B, Tauber S,. Diagnosis and management of carcinoma of unknown primary in the head and neck. Eur Arch Otorhinolaryngol 2003; 260: 436-443.
2. Regelink G, Brouwer J, de Bree R, et al. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities. Eur J Nucl Med Mol Imaging 2002; 29: 1024-1030.
3. Grau C, Johansen LV, Jakobsen J, Geertsen P, Andersen E, Jensen BB,. Cervical lymph node metastases from unknown primary tumours: results from a national survey by the Danish Society for Head and Neck Oncology. Radiother Oncol 2000; 55: 121-129.
4. Strojan P, Aničin A,. Combined surgery and postoperative radiotherapy for cervical lymph node metastases from an unknown primary tumour. Radiother Oncol 1998; 49: 33-40.
5. Strojan P, Ferlito A, Medina JE, et al. Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. Head Neck 2011 (in press).
6. Nieder C, Gregoire V, Ang KK,. Cervical lymph node metastases from occult squamous cell carcinoma: cut down a tree to get an apple? Int J Radiat Oncol Biol Phys 2001; 50: 727-733.
7. Colletier PJ, Garden AS, Morrison WH, Goepfert H, Geara F, Ang KK,. Postoperative radiation for squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: outcomes and patterns of failure. Head Neck 1998; 20: 674-681.
8. Aslani M, Sultanem K, Voung T, Hier M, Niazi T, Shenouda G,. Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: is there a need for neck dissection? Head Neck 2007; 29: 585-590.
9. Coster JR, Foote RL, Olsen KD, Jack SM, Schaid DJ, DeSanto LW,. Cervical nodal metastasis of squamous cell carcinoma of unknown origin: indications for withholding radiation therapy. Int J Radiat Oncol Biol Phys 1990; 23: 743-749.
10. Miller FR, Karnad AB, Eng T, Hussey DH, McGuff HS, Otto RA,. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy. Head Neck 2008; 30: 28-34.
11. Patel RS, Clark J, Wyten R, Gao K, O'Brien CJ,. Squamous cell carcinoma from an unknown head and neck primary site: a "selective treatment" approach. Arch Otolaryngol Head Neck Surg 2007; 133: 1282-1287.
12. Iganej S, Kagan R, Anderson P, et al. Metastatic squamous cell carcinoma of the neck from an unknown primary: management options and patterns of relapse. Head Neck 2002; 24: 236-246.
13. Strojan P, Ferlito A, Langendijk JA, Silver CE,. Indications for radiotherapy after neck dissection. Head Neck 2010 Nov 10 [Epub ahead of print].
14. Suárez C, Llorente JL, Nuñez F, Diaz C, Gomez J,. Neck dissection with or without postoperative radiotherapy in supraglottic carcinomas. Otolaryngol Head Neck Surg 1993; 109: 3-9.
15. Rodrigo JP, Maseda E, Maldonado M, et al. Efficacy of postoperative radiation therapy for squamous cell carcinoma of the head and neck: results of a prospective randomised clinical trial. Acta Otorrinolaringol Esp 2004; 55: 415-419 [in Spanish].
16. Lu X, Hu C, Ji Q, Shen C, Feng Y,. Squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: the impact of radiotherapy. Tumori 2009; 95: 185-190.
17. Jereczek-Fossa BA, Jassem J, Orecchia R,. Cervical lymph node metastases of squamous cell carcinoma of unknown primary. Cancer Treat Rev 2004; 30: 153-164.
18. Rödel RM, Matthias C, Blomeyer BD, Wolff HA, Jung K, Christiansen H,. Impact of distant metastasis in patients with cervical lymph node metastases from cancer of an unknown primary site. Ann Otol Rhinol Laryngol 2009; 118: 662-669.
19. Beldì D, Jereczek-Fossa BA, D'Onofrio A, et al. Role of radiotherapy in the treatment of cervical lymph node metastases from unknown primary site: retrospective analysis of 113 patients. Int J Radiat Oncol Biol Phys 2007; 69: 1051-1058.
20. Wallace A, Richards GM, Harari PM, et al. Head and neck squamous cell carcinoma from unknown primary site. Am J Otolaryngol 2011; 32: 286-290.
21. Reddy SP, Marks JE,. Metastatic carcinoma in the cervical lymph node from an unknown primary site: results of bilateral neck plus mucosal irradiation vs. ipsilateral neck irradiation. Int J Radiat Oncol Biol Phys 1997; 37: 797-802.
22. Harper CS, Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ, Million RR,. Cancer in neck nodes with unknown primary site: role of mucosal radiotherapy. Head Neck 1990; 12: 463-469.
23. Sinnathamby K, Peters LJ, Laidlaw C, Hughes PG,. The occult head and neck primary: to treat or not to treat? Clin Oncol (R Coll Radiol) 1997; 9: 322-329.
24. Fernández JA, Suárez C, Martínez JA, Llorente JL, Rodrigo JP, Alvarez JC,. Metastatic squamous cell carcinoma in cervical lymph nodes from an unknown primary tumour: prognostic factors. Clin Otolaryngol Allied Sci 1998; 23: 158-163.
25. Ligey A, Gentil J, Créhange G, et al. Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary. Radiother Oncol 2009; 93: 483-487.
26. Weir L, Keane T, Cummings B, et al. Radiation treatment of cervical lymph node metastases from an unknown primary: an analysis of outcome by treatment volume and other prognostic factors. Radiother Oncol 1995; 35: 206-211.
27. Klem ML, Mechalakos JG, Wolden SL, et al. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy. Int J Radiat Oncol Biol Phys 2008; 70: 1100-1107.
28. Madani I, Vakaet L, Bonte K, Boterberg T, De Neve W,. Intensity-modulated radiotherapy for cervical lymph node metastases from unknown primary cancer. Int J Radiat Oncol Biol Phys 2008; 71: 1158-1166.
29. Lu H, Yao M, Tan H,. Unknown primary head and neck cancer treated with intensity-modulated radiation therapy: to what extent the volume should be irradiated. Oral Oncol 2009; 45: 474-479.
30. Frank SJ, Rosenthal DI, Petsuksiri J, et al. Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M.D. Anderson Cancer Center outcomes and patterns of failure. Int J Radiat Oncol Biol Phys 2010; 78: 1005-1010.
31. Sher DJ, Balboni TA, Haddad RI, et al. Efficacy and toxicity of chemoradiotherapy using intensity-modulated radiotherapy for unknown primary of head and neck. Int J Radiat Oncol Biol Phys 2011; 80: 1405-1411.
32. Chen AM, Li BQ, Farwell DG, Marsano J, Vijayakumar S, Purdy JA,. Improved dosimetric and clinical outcomes with intensity-modulated radiotherapy for head-and-neck cancer of unknown primary origin. Int J Radiat Oncol Biol Phys 2011; 79: 756-762.
33. Vergeer MR, Doornaert PA, Rietveld DH, Leemans CR, Slotman BJ, Langendijk JA,. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program. Int J Radiat Oncol Biol Phys 2009; 74: 1-8.
34. Ferlito A, Kowalski LP, Silver CE, Shaha AR, Rinaldo A, Byers RM,. The use and misuse of level IA dissection for head and neck cancer. Acta Otolaryngol 2002; 122: 553-555.
35. Ferlito A, Rinaldo A,. Is radical neck dissection a current option for neck disease? Laryngoscope 2008; 118: 1717-1718.
36. de Braud F, Heilbrun LK, Ahmed K, et al. Metastatic squamous cell carcinoma of an unknown primary localized to the neck. Advantages of an aggressive treatment. Cancer 1989; 64: 510-515.
37. Boscolo-Rizzo P, Da Mosto MC, Gava A, Marchiori C,. Cervical lymph node metastases from occult squamous cell carcinoma: analysis of 82 cases. ORL J Otorhinolaryngol Relat Spec 2006; 68: 189-194.
38. Kirschner MJ, Fietkau R, Waldfahrer F, Iro H, Sauer R,. Therapy for cervical lymph node metastases of unknown primary tumor. Strahlenther Onkol 1997; 173: 362-368 [in German].
39. Argiris A, Smith SM, Stenson K, et al. Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary. Ann Oncol 2003; 14: 1306-1311.
40. Shehadeh NJ, Ensley JF, Kucuk O, et al. Benefit of postoperative chemoradiotherapy for patients with unknown primary squamous cell carcinoma of the head and neck. Head Neck 2006; 28: 1090-1098.
41. Chen AM, Farwell DG, Lau DH, Li BQ, Luu Q, Donald PJ,. Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affects the therapeutic ratio? Int J Radiat Oncol Biol Phys 2010 Oct 7 [Epub ahead of print].
42. Pignon JP, le Maître A, Maillard E, Bourhis J,; MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009; 92: 4-14.
43. Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck 2005; 27: 843-850.
44. Ahmed KA, Robbins KT, Wong F, Salazar JE,. Efficacy of concomitant chemoradiation and surgical salvage for N3 nodal disease associated with upper aerodigestive tract carcinoma. Laryngoscope 2000; 110: 1789-1793.
45. Corry J, Peters L, Fisher R, et al. N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders-results of Trans Tasman Radiation Oncology Group Study 98.02. Head Neck 2008; 30: 737-742.
46. Corry J, Rischin D,. Induction chemotherapy in head and neck cancer: closer to an answer? Lancet Oncol 2011; 12: 113-114.
47. Ragin CC, Taioli E,. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 2007; 121: 1813-1820.
48. Marur S, D'souza G, Westra WH, Forastiere AA,. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010; 11: 781-789.
49. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261-269.
50. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
51. Porceddu SV, Jarmolowski E, Hicks RJ, et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck 2006; 27: 175-181.
52. Corry J, Peter LJ, Rischin D,. Optimising the therapeutic ration in head and neck cancer. Lancet Oncol 2010; 11: 287-291.
53. Licitra L, Perrone F, Bossi P, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 2006; 24: 5630-5636.